Immediate Impact
1 from Science/Nature 69 standout
Citing Papers
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Deciphering breast cancer: from biology to the clinic
2023 Standout
Works of A Stone being referenced
MA 11.02 Circulating Tumor DNA in Early Stage NSCLC: High Sensitivity Analysis in Low Burden Disease. LUCID Study Update
2017
Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysis
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| A Stone | 127 | 52 | 122 | 67 | 21 | 308 | |
| Max Parmar | 163 | 63 | 178 | 31 | 21 | 344 | |
| Mathilde Marchand | 248 | 47 | 63 | 25 | 19 | 367 | |
| Malek B. Hannouf | 130 | 55 | 129 | 11 | 27 | 329 | |
| Raghu Rajan | 90 | 41 | 101 | 23 | 20 | 360 | |
| Ahmed Abugharib | 62 | 30 | 199 | 45 | 17 | 296 | |
| Robin Schaffar | 192 | 62 | 123 | 14 | 16 | 328 | |
| Carmela Caballero | 157 | 81 | 134 | 8 | 32 | 341 | |
| Elaine Luterstein | 135 | 25 | 214 | 7 | 16 | 341 | |
| Dinesh de Alwis | 266 | 22 | 69 | 21 | 19 | 354 | |
| Tamy Kim | 82 | 58 | 30 | 76 | 13 | 294 |
All Works
Login with ORCID to disown or claim papers
Loading papers...